vs
Side-by-side financial comparison of Ouster, Inc. (OUST) and STEM, INC. (STEM). Click either name above to swap in a different company.
Ouster, Inc. is the larger business by last-quarter revenue ($62.2M vs $47.1M, roughly 1.3× STEM, INC.). On growth, Ouster, Inc. posted the faster year-over-year revenue change (106.6% vs -15.6%). Over the past eight quarters, Ouster, Inc.'s revenue compounded faster (54.8% CAGR vs 36.1%).
Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
OUST vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.2M | $47.1M |
| Net Profit | — | $-16.0M |
| Gross Margin | 60.2% | 48.9% |
| Operating Margin | 1.5% | -17.7% |
| Net Margin | — | -33.9% |
| Revenue YoY | 106.6% | -15.6% |
| Net Profit YoY | — | 68.8% |
| EPS (diluted) | $0.10 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.2M | $47.1M | ||
| Q3 25 | $39.5M | $38.2M | ||
| Q2 25 | $35.0M | $38.4M | ||
| Q1 25 | $32.6M | $32.5M | ||
| Q4 24 | $30.1M | $55.8M | ||
| Q3 24 | $28.1M | $29.3M | ||
| Q2 24 | $27.0M | $34.0M | ||
| Q1 24 | $25.9M | $25.5M |
| Q4 25 | — | $-16.0M | ||
| Q3 25 | $-21.7M | $-23.8M | ||
| Q2 25 | $-20.6M | $202.5M | ||
| Q1 25 | $-22.0M | $-25.0M | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | $-25.6M | $-148.3M | ||
| Q2 24 | $-23.9M | $-582.3M | ||
| Q1 24 | $-23.8M | $-72.3M |
| Q4 25 | 60.2% | 48.9% | ||
| Q3 25 | 42.1% | 35.5% | ||
| Q2 25 | 45.2% | 33.4% | ||
| Q1 25 | 41.3% | 32.4% | ||
| Q4 24 | 43.8% | -4.4% | ||
| Q3 24 | 38.3% | 21.2% | ||
| Q2 24 | 33.7% | 27.6% | ||
| Q1 24 | 28.6% | -95.0% |
| Q4 25 | 1.5% | -17.7% | ||
| Q3 25 | -61.4% | -33.6% | ||
| Q2 25 | -76.5% | -34.8% | ||
| Q1 25 | -73.0% | -65.0% | ||
| Q4 24 | -85.1% | -84.4% | ||
| Q3 24 | -98.0% | -493.2% | ||
| Q2 24 | -93.6% | -1705.5% | ||
| Q1 24 | -99.5% | -267.0% |
| Q4 25 | — | -33.9% | ||
| Q3 25 | -55.0% | -62.2% | ||
| Q2 25 | -58.8% | 527.8% | ||
| Q1 25 | -67.5% | -76.9% | ||
| Q4 24 | — | -91.6% | ||
| Q3 24 | -91.1% | -506.3% | ||
| Q2 24 | -88.4% | -1712.6% | ||
| Q1 24 | -91.9% | -283.9% |
| Q4 25 | $0.10 | $-4.40 | ||
| Q3 25 | $-0.37 | $-2.84 | ||
| Q2 25 | $-0.38 | $-1.79 | ||
| Q1 25 | $-0.42 | $-0.15 | ||
| Q4 24 | $-0.46 | $-15.29 | ||
| Q3 24 | $-0.54 | $-18.24 | ||
| Q2 24 | $-0.53 | $-71.81 | ||
| Q1 24 | $-0.55 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $208.6M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $261.7M | $-249.4M |
| Total Assets | $349.5M | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $208.6M | $48.9M | ||
| Q3 25 | $244.5M | $43.1M | ||
| Q2 25 | $226.5M | $40.8M | ||
| Q1 25 | $168.2M | $58.6M | ||
| Q4 24 | $172.0M | $56.3M | ||
| Q3 24 | $151.4M | $75.4M | ||
| Q2 24 | $184.2M | $89.6M | ||
| Q1 24 | $187.8M | $112.8M |
| Q4 25 | $261.7M | $-249.4M | ||
| Q3 25 | $247.4M | $-235.7M | ||
| Q2 25 | $221.0M | $-214.1M | ||
| Q1 25 | $167.9M | $-417.5M | ||
| Q4 24 | $180.9M | $-398.4M | ||
| Q3 24 | $171.7M | $-344.1M | ||
| Q2 24 | $170.6M | $-203.2M | ||
| Q1 24 | $167.2M | $371.6M |
| Q4 25 | $349.5M | $308.9M | ||
| Q3 25 | $353.8M | $362.6M | ||
| Q2 25 | $321.8M | $379.2M | ||
| Q1 25 | $268.6M | $405.1M | ||
| Q4 24 | $276.1M | $437.4M | ||
| Q3 24 | $255.2M | $537.8M | ||
| Q2 24 | $309.9M | $691.5M | ||
| Q1 24 | $317.7M | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.4M | $8.2M |
| Free Cash FlowOCF − Capex | $-37.2M | — |
| FCF MarginFCF / Revenue | -59.8% | — |
| Capex IntensityCapex / Revenue | 35.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-64.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-15.4M | $8.2M | ||
| Q3 25 | $-18.3M | $11.4M | ||
| Q2 25 | $-1.3M | $-21.3M | ||
| Q1 25 | $-4.9M | $8.5M | ||
| Q4 24 | $-2.6M | $-14.7M | ||
| Q3 24 | $-3.8M | $-9.4M | ||
| Q2 24 | $-21.6M | $-11.9M | ||
| Q1 24 | $-5.7M | $-621.0K |
| Q4 25 | $-37.2M | — | ||
| Q3 25 | $-20.0M | — | ||
| Q2 25 | $-2.2M | — | ||
| Q1 25 | $-5.4M | — | ||
| Q4 24 | $-4.0M | — | ||
| Q3 24 | $-4.3M | — | ||
| Q2 24 | $-22.0M | — | ||
| Q1 24 | $-7.1M | — |
| Q4 25 | -59.8% | — | ||
| Q3 25 | -50.7% | — | ||
| Q2 25 | -6.3% | — | ||
| Q1 25 | -16.6% | — | ||
| Q4 24 | -13.3% | — | ||
| Q3 24 | -15.4% | — | ||
| Q2 24 | -81.5% | — | ||
| Q1 24 | -27.4% | — |
| Q4 25 | 35.0% | — | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 5.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
